type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size font family time roman align center license collaborative research agreement style margin margin bottom text indent font size font family time roman license collaborative research agreement agreement effective december nbsp effective date between novartis institute biomedical research delaware corporation with principal place business massachusetts avenue cambridge novartis intellia therapeutic delaware corporation with principal place business brookline street suite cambridge intellia novartis intellia each separately referred party collectively referred party style margin margin bottom text indent font size font family time roman whereas intellia biopharmaceutical company that licensed developing crispr system that permit genomic editing research development commercialization therapeutic prophylactic palliative application style margin margin bottom text indent font size font family time roman whereas novartis posse expertise discovering developing manufacturing marketing selling pharmaceutical product worldwide style margin margin bottom text indent font size font family time roman whereas party wish further develop intellia platform discover therapeutic prophylactic palliative product service generated through that technology style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman consideration respective representation warranty covenant agreement contained herein other valuable consideration receipt sufficiency which hereby acknowledged party agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center certain definition rule interpretation style margin margin bottom font size font family time roman section nbsp certain definition style margin margin bottom text indent font size font family time roman purpose this agreement following term whether used singular plural form will have meaning forth below style margin margin bottom text indent font size font family time roman accounting standard mean with respect novartis international financial reporting standard ifrs with respect intellia generally accepted accounting principle gaap each case generally consistently applied throughout party organization style margin margin bottom text indent font size font family time roman additional selected product mean product directed additional selected target that researched developed commercialized novartis affiliate their sublicensees style margin margin bottom text indent font size font family time roman additional selected target meaning forth section nbsp style margin margin bottom text indent font size font family time roman advanced cart product mean cart product directed cart therapeutic target certain advanced cart target that novartis affiliate their sublicensees researching developing commercializing style margin margin bottom text indent font size font family time roman advanced cart target mean that specified cart product directed toward style margin margin bottom text indent font size font family time roman affiliate mean with respect specified person person that directly indirectly control controlled under common control with such person purpose this definition control controlled mean direct indirect ownership more share stock entitled vote election director case corporation ownership more equity interest case other type legal entity status general partner partnership other arrangement whereby person control right control board director equivalent governing body corporation other entity ability otherwise cause direction management policy corporation other style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman entity party acknowledge that case entity organized under applicable certain country where maximum percentage ownership permitted applicable foreign investor than such lower percentage will substituted preceding sentence provided that such foreign investor power direct management policy such entity affiliate shall include investment fund other person entity controlled such investment fund style margin margin bottom text indent font size font family time roman agreement meaning forth preamble will include avoidance doubt exhibit attached hereto style margin margin bottom text indent font size font family time roman agreement term meaning forth section nbsp style margin margin bottom text indent font size font family time roman alliance manager meaning forth section nbsp style margin margin bottom text indent font size font family time roman annual sale mean with respect product sale such product during calendar year style margin margin bottom text indent font size font family time roman applicable mean applicable national supranational federal state local foreign statute ordinance principle common rule regulation standard judgment order writ injunction decree arbitration award agency requirement license permit governmental authority including rule regulation guideline other requirement regulatory authority style margin margin bottom text indent font size font family time roman approval milestone meaning forth section nbsp style margin margin bottom text indent font size font family time roman approved internalized target meaning forth section nbsp style margin margin bottom text indent font size font family time roman auditor meaning forth section nbsp style margin margin bottom text indent font size font family time roman business mean other than saturday sunday public holiday during which bank authorized closed cambridge massachusetts style margin margin bottom text indent font size font family time roman calendar quarter mean each calendar quarter ending march nbsp nbsp june nbsp nbsp september nbsp december nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman calendar year mean each calendar year ending december nbsp style margin margin bottom text indent font size font family time roman caribou mean caribou bioscience delaware corporation style margin margin bottom text indent font size font family time roman caribou berkeley vienna agreement mean exclusive license among caribou regent university california university vienna dated amended from time time style margin margin bottom text indent font size font family time roman caribou intellia license agreement mean license agreement between caribou intellia dated amended from time time style margin margin bottom text indent font size font family time roman caribou wageningen agreement mean exclusive assignment agreement between caribou wageningen universiteit dated amended from time time style margin margin bottom text indent font size font family time roman chimeric antigen receptor mean style margin margin bottom text indent font size font family time roman cart mean engineered modified cell style margin margin bottom text indent font size font family time roman cart budget meaning forth section nbsp style margin margin bottom text indent font size font family time roman cart crispr target mean style margin margin bottom text indent font size font family time roman cart field mean vivo cart therapeutic prophylactic palliative human disease vivo meant that modification cell occurs vivo cart then administered patient style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman cart product mean product service that novartis affiliate their sublicensees researching developing commercializing cart field research development manufacture sale import which practice intellia intellectual property collaboration intellectual property style margin margin bottom text indent font size font family time roman cart program meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman cart program target mean style margin margin bottom text indent font size font family time roman cart research plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman cart steering committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman cart target product mean includes advanced cart product directed style margin margin bottom text indent font size font family time roman cart therapeutic target mean style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman chair meaning forth section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman collaboration meaning forth section nbsp style margin margin bottom text indent font size font family time roman collaboration intellectual property mean intellectual property right created conceived reduced practice either jointly party their affiliate their employee agent subcontractor during research term conduct collaboration collaboration intellectual property will consist collaboration platform intellectual property collaboration product intellectual property style margin margin bottom text indent font size font family time roman collaboration platform intellectual property mean collaboration intellectual property relating nbsp nbsp improvement modification style margin margin bottom text indent font size font family time roman collaboration product mean product cart product vivo product style margin margin bottom text indent font size font family time roman collaboration product intellectual property mean collaboration intellectual property other than collaboration platform intellectual property style margin margin bottom text indent font size font family time roman commercialization commercialize mean style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman commercially reasonable effort mean those effort resource consistent with usual practice relevant party pursuing research development commercialization similarly situated pharmaceutical product service similar stage development commercialization style margin margin bottom text indent font size font family time roman committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman confidential information mean know other information including proprietary information material whether patentable regarding party technology product service business information objective that treated confidential disclosing party regular course business otherwise designated confidential disclosing party whether existing before after effective date avoidance doubt nbsp provided novartis will deemed novartis confidential information nbsp provided intellia will deemed intellia confidential information nbsp term this agreement will deemed confidential information both party style margin margin bottom text indent font size font family time roman confidentiality agreement mean style margin margin bottom text indent font size font family time roman contract year mean each successive twelve month period following effective date style margin margin bottom text indent font size font family time roman control controlled mean with respect intellectual property right possession party whether ownership license otherwise ability grant access license sublicense such right property without nbsp violating term agreement other arrangement with third party existence nbsp having obligation royalty other consideration therefor that other contracting party decline assume pursuant election procedure section nbsp section nbsp applicable time such party would first required hereunder grant other party such access license sublicense style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman crispr mean clustered regularly interspaced short palindromic repeat style margin margin bottom text indent font size font family time roman crispr system mean style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman develop development mean style margin margin bottom text indent font size font family time roman development milestone meaning forth section nbsp style margin margin bottom text indent font size font family time roman diligence package meaning forth section nbsp style margin margin bottom text indent font size font family time roman directed directed directed toward mean with respect specific product that product derives therapeutic prophylactic palliative benefit from style margin margin bottom text indent font size font family time roman disclaiming party meaning forth section nbsp style margin margin bottom text indent font size font family time roman effective date meaning forth preamble style margin margin bottom text indent font size font family time roman mean european medicine agency successor agency thereto style margin margin bottom text indent font size font family time roman equity agreement mean that unit purchase agreement dated september nbsp among intellia therapeutic atlas venture fund novartis that amended restated operating agreement intellia therapeutic dated september nbsp each amended waived superseded from time time style margin margin bottom text indent font size font family time roman mean european union membership constituted from time time successor thereto style margin margin bottom text indent font size font family time roman excluded intellia licensed intellectual property meaning forth section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman excluded vivo target meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman excluded novartis licensed platform intellectual property meaning forth section nbsp style margin margin bottom text indent font size font family time roman expert meaning forth section nbsp style margin margin bottom text indent font size font family time roman extension meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean united state food drug administration successor agency thereto style margin margin bottom text indent font size font family time roman first commercial sale mean first length sale product novartis affiliate their licensee third party intellia product intellia affiliate their licensee third party country following regulatory approval such product intellia product applicable that country such regulatory approval required sale product intellia product country date upon which such product intellia product first commercially launched such country style margin margin bottom text indent font size font family time roman rate mean rate defined herein annum based yearly time full time equivalent qualified scientific employee during research term consisting total hour annum rated daily basis necessary annum amount divided produce rate whole consisting hour such rate restricted scientific work purpose this definition qualified scientific employee mean scientist with adequate scientific knowledge training experience conduct work assigned style margin margin bottom text indent font size font family time roman fpfd mean with respect clinical trial first dosing first patient such clinical trial style margin margin bottom text indent font size font family time roman generic equivalent mean with respect particular product country product that nbsp regulatory approval such country pursuant regulatory process governing approval generic interchangeable biosimilar pharmaceutical style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman biological product based then current standard regulatory approval such country where such regulatory approval relied incorporated clinical data generated either party pursuant this agreement obtained using abbreviated expedited other similar process nbsp during agreement term owned licensed novartis case product commercialized novartis affiliate their sublicensees intellia case intellia product commercialized intellia affiliate their sublicensees under this agreement nbsp sold same country relevant product third party that sublicensee novartis case product commercialized novartis affiliate their sublicensees intellia case intellia product commercialized intellia affiliate their sublicensees that purchase such product chain distribution that included novartis intellia applicable their respective affiliate sublicensees style margin margin bottom text indent font size font family time roman mean good laboratory practice contemplated part united state equivalent corresponding provision applicable other jurisdiction style margin margin bottom text indent font size font family time roman toxicology mean toxicology study that commenced compliance with manner such that resulting data would admissible applicable regulatory authority support style margin margin bottom text indent font size font family time roman government authority mean domestic foreign entity exercising executive legislative judicial regulatory administrative function pertaining government including governmental authority agency department board commission court tribunal judicial body instrumentality union nation federation nation state municipality county locality other political subdivision thereof style margin margin bottom text indent font size font family time roman mean hematopoietic stem cell style margin margin bottom text indent font size font family time roman budget meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman field mean vivo crispr system directed target research develop commercialize including without limitation provision service extent required such commercialization product service directed target therapeutic prophylactic palliative human disease purpose this definition vivo mean that crispr system modification occurs vivo modified hscs then administered patient style margin margin bottom text indent font size font family time roman product mean product service that novartis affiliate their sublicensees researching developing commercializing field research development manufacture sale import which practice intellia intellectual property collaboration intellectual property style margin margin bottom text indent font size font family time roman program meaning forth section nbsp style margin margin bottom text indent font size font family time roman research plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman steering committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman target product mean includes product directed style margin margin bottom text indent font size font family time roman included intellia licensed intellectual property meaning forth section nbsp style margin margin bottom text indent font size font family time roman included novartis licensed platform intellectual property meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean investigational drug application filed with corresponding application investigation product other country group country defined applicable regulation filed with regulatory authority such given country group country style margin margin bottom text indent font size font family time roman indemnified party meaning forth section nbsp style margin margin bottom text indent font size font family time roman indemnifying party meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman indication mean specific disease impairment medical condition that intended subject therapeutic prophylactic palliative product service style margin margin bottom text indent font size font family time roman insolvency event mean nbsp party cease function going concern suspending discontinuing business nbsp party becomes insolvent unable debt they become nbsp party subject voluntary involuntary bankruptcy proceeding instituted behalf against such party except involuntary bankruptcy proceeding that dismissed within nbsp administrative receiver receiver manager interim receiver custodian sequestrator similar officer appointed party nbsp notice convene director shareholder creditor meeting purpose passing resolution wind party issued such resolution passed nbsp resolution will have been passed party party director make application administration order appoint administrator nbsp party proposes make general assignment composition arrangement with benefit some creditor nbsp party make suspends threatens suspend making payment some creditor submits type similar voluntary arrangement style margin margin bottom text indent font size font family time roman intellectual property right mean patent right know style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman intellia product mean product service field directed intellia selected target style margin margin bottom text indent font size font family time roman intellia intellectual property mean intellectual property right controlled intellia affiliate relating crispr system necessary useful research develop manufacture commercialize product service field cart field vivo field that existence nbsp effective date style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman intellia sale meaning forth section nbsp style margin margin bottom text indent font size font family time roman intellia licensed intellectual property meaning forth section nbsp style margin margin bottom text indent font size font family time roman intellia platform mean intellia proprietary crispr system claimed intellia intellectual property together with improvement thereto including collaboration platform intellectual property style margin margin bottom text indent font size font family time roman intellia selected target mean target selected intellia exclusive research under this agreement accordance with section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman vivo budget meaning forth section nbsp style margin margin bottom text indent font size font family time roman vivo field mean crispr system vivo treatment prevention human disease vivo meant that modification relevant target occurs vivo style margin margin bottom text indent font size font family time roman vivo product mean product service that novartis affiliate their sublicensees researching developing commercializing vivo field research development manufacture sale import which practice intellia intellectual property collaboration intellectual property style margin margin bottom text indent font size font family time roman vivo program meaning forth section nbsp style margin margin bottom text indent font size font family time roman vivo research plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman vivo target product mean includes vivo product directed novartis selected vivo target style margin margin bottom text indent font size font family time roman vivo steering committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman invoice mean invoice substantially form attached exhibit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman joint steering committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman license agreement meaning forth section nbsp style margin margin bottom text indent font size font family time roman know mean information invention trade secret technology whether proprietary patentable whether stored transmitted oral documentary electronic other form know will include invention idea concept formula method procedure design composition plan document data discovery development technique protocol specification work authorship biological material information relating research development plan experiment result compound therapeutic lead candidate product service service protocol clinical preclinical data clinical trial result manufacturing information plan style margin margin bottom text indent font size font family time roman labeled indication mean indication product forth product label approved relevant regulatory authority initial labeled indication mean labeled indication upon product initial receipt regulatory approval regardless number indication described additional labeled indication mean labeled indication added product label after initial labeled indication expanding scope previous labeled indication which approved supplemental regulatory approval snda sbla style margin margin bottom text indent font size font family time roman loss meaning forth section nbsp style margin margin bottom text indent font size font family time roman loss market exclusivity mean with respect product country sale such product that country calendar year than compared with sale such product that country calendar year immediately preceding marketing sale first generic equivalent such product style margin margin bottom text indent font size font family time roman material mean material provided transferred party affiliate other party affiliate connection with collaboration style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman case biological material term will encompass medium which material provided part material modified unmodified progeny descendant from material style margin margin bottom text indent font size font family time roman milestone payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman milestone meaning forth section nbsp style margin margin bottom text indent font size font family time roman sale mean sale recorded novartis affiliate licensee style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman nominated cart program target meaning forth section nbsp style margin margin bottom text indent font size font family time roman nominated target meaning forth section nbsp style margin margin bottom text indent font size font family time roman novartis background intellectual property mean compound identified exhibit patent right know covering claiming such compound including composition matter formulation method manufacture only with regard such compound clarification purpose novartis background intellectual property include right other compound including their composition matter formulation method manufacture that covered claimed same patent right know those covering claiming compound identified exhibit style margin margin bottom text indent font size font family time roman novartis licensed platform intellectual property meaning forth section nbsp style margin margin bottom text indent font size font family time roman novartis other background intellectual property mean patent right know identified exhibit style margin margin bottom text indent font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman novartis selected product mean product directed novartis selected target that researched developed commercialized novartis affiliate their sublicensees style margin margin bottom text indent font size font family time roman novartis selected target mean target selected novartis exclusive research under this agreement accordance with section nbsp style margin margin bottom text indent font size font family time roman novartis selected vivo product mean vivo product directed novartis selected vivo target that researched developed commercialized novartis affiliate their sublicensees style margin margin bottom text indent font size font family time roman novartis selected vivo target meaning forth section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman paragraph certification meaning forth section nbsp style margin margin bottom text indent font size font family time roman party party meaning forth preamble style margin margin bottom text indent font size font family time roman patent right mean patent substitution division continuation continuation part reissue reexamination extension thereof supplemental protection certificate relating thereto counterpart thereof substantial equivalent country collectively patent application provisional application foregoing patent application including right claim benefit priority right patent application under applicable convention style margin margin bottom text indent font size font family time roman person mean corporation limited general partnership limited liability company joint venture trust unincorporated association governmental body authority bureau agency other entity body individual style margin margin bottom text indent font size font family time roman personal information meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman phase trial mean study human safety dose ranging efficacy product further defined nbsp foreign counterpart conducted anywhere world style margin margin bottom text indent font size font family time roman phase trial mean small scale phase trial intended principally demonstrate proof concept pharmaceutical product human determine whether what manner pursue regulatory approval such product style margin margin bottom text indent font size font family time roman phase trial mean controlled dose ranging phase trial pharmaceutical product further evaluate efficacy safety product target patient population define product optimal dosing regimen conducted anywhere world case that designed obtain data select particular used phase trial style margin margin bottom text indent font size font family time roman phase trial mean with respect pharmaceutical product clinical trial sufficient number human patient that designed establish that such pharmaceutical product safe efficacious intended define warning precaution adverse reaction that associated with such pharmaceutical product dosage range prescribed that directly support regulatory approval label expansion such pharmaceutical product described foreign counterpart conducted anywhere world style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman practice mean with respect patent right make sell offer sale import have made have used have sold have offered sale have imported with respect know practice disclose have used practiced disclosed style margin margin bottom text indent font size font family time roman prescriber mean united state healthcare professional authorized prescribe pharmaceutical product issue hospital order pharmaceutical product those other allied professional that part treatment team recognized this purpose commercialization plan applicable style margin margin bottom text indent font size font family time roman product mean without distinction collaboration product style margin margin bottom text indent font size font family time roman program mean without distinction program cart program vivo program style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman regulatory approval mean with respect pharmaceutical product service country jurisdiction approval registration license authorization from regulatory authority country other jurisdiction that reasonably necessary market sell pharmaceutical product provide service such country jurisdiction including applicable pricing reimbursement approval style margin margin bottom text indent font size font family time roman regulatory authority mean governmental authority responsible authorizing approving marketing sale pharmaceutical product service jurisdiction japanese ministry health labor welfare corresponding national regional regulatory agency organization style margin margin bottom text indent font size font family time roman regulatory filing mean with respect pharmaceutical product service submission regulatory authority appropriate regulatory application will include without limitation submission regulatory advisory board marketing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman authorization application supplement amendment thereto avoidance doubt term regulatory filing will include drug application corresponding application under applicable other jurisdiction style margin margin bottom text indent font size font family time roman research plan mean collectively without distinction research plan cart research plan vivo research plan style margin margin bottom text indent font size font family time roman research program mean without distinction program cart program vivo program style margin margin bottom text indent font size font family time roman research term meaning forth section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman royalty meaning forth section nbsp style margin margin bottom text indent font size font family time roman royalty term mean with respect each product each country style margin margin bottom text indent font size font family time roman sale milestone meaning forth section nbsp style margin margin bottom text indent font size font family time roman sale milestone payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman senior officer mean style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman subcommittee meaning forth section nbsp style margin margin bottom text indent font size font family time roman target mean style margin margin bottom text indent font size font family time roman third party mean person other than intellia novartis their respective affiliate style margin margin bottom text indent font size font family time roman third party collaboration meaning forth section nbsp style margin margin bottom text indent font size font family time roman valid claim mean claim issued unexpired patent included within intellia intellectual property collaboration intellectual property style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp rule interpretation style margin margin bottom text indent font size font family time roman this agreement unless otherwise specified style margin margin bottom margin left text indent font size font family time roman includes including will mean including without limitation will mean style margin margin bottom margin left text indent font size font family time roman reference article this agreement includes section that article reference section this agreement includes subsection that section style margin margin bottom margin left text indent font size font family time roman herein hereby hereunder hereof other equivalent word refer this agreement entirety solely particular portion this agreement which such word used style margin margin bottom margin left text indent font size font family time roman party includes permitted assignee respective successor title substantially whole undertaking style margin margin bottom margin left text indent font size font family time roman statute statutory instrument their provision construed reference that statute statutory instrument such provision same have been from time time hereafter amended enacted style margin margin bottom margin left text indent font size font family time roman word denoting singular will include plural vice versa word denoting gender will include gender style margin margin bottom margin left text indent font size font family time roman except where otherwise indicated reference license will include sublicense reference licensee will include sublicensee unless context otherwise provides style margin margin bottom margin left text indent font size font family time roman exhibit form part operative provision this agreement reference this agreement will unless context otherwise requires include reference exhibit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman heading this agreement convenience only will considered interpretation this agreement style margin margin bottom margin left text indent font size font family time roman term condition this agreement result negotiation between party this agreement will construed favor against party reason extent which either party participated preparation this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center collaboration style margin margin bottom font size font family time roman section nbsp overview research term effort style margin margin bottom text indent font size font family time roman goal party will engage collaborative research activity accordance with term condition this agreement research plan forth research plan goal these activity identify research therapeutic prophylactic palliative product service utilizing nbsp vivo application intellia platform described research plan section nbsp this agreement program nbsp vivo cart application intellia platform described cart research plan section nbsp this agreement cart program nbsp vivo application intellia platform described vivo research plan section nbsp this agreement vivo program cart program program vivo program collectively comprise collaboration during research term each party shall conduct activity relating field cart field subject section nbsp vivo field well identification target research development product directed such target under corresponding research plan cart research plan subject section nbsp vivo research plan unless otherwise expressly provided this agreement style margin margin bottom text indent font size font family time roman research term unless terminated accordance with section nbsp collaboration will commence effective date expire fifth anniversary effective date research term style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman effort information sharing generally during research term each party will commercially reasonable effort carry activity assigned relevant research plan without limiting other obligation forth this agreement time during research term each party will keep other party reasonably timely informed collaboration research effort result thereof style margin margin bottom font size font family time roman section nbsp program style margin margin bottom text indent font size font family time roman program generally program party will research potential therapeutic prophylactic palliative application intellia platform field provided research plan party will initially conduct research activity field under research plan with respect target nominated steering committee each nominated target product service directed those nominated target selection pursuant will made from pool nominated target style margin margin bottom text indent font size font family time roman scope program activity research plan style margin margin bottom margin left text indent font size font family time roman initial research plan program research plan will agreed upon party later than agreed shall deemed part this agreement amend research plan from time time nominate remove target from scope program remove modify research development activity assigned either party under program style margin margin bottom margin left text indent font size font family time roman steering committee will amend research plan necessary reflect scientific development program research activity progress well nomination selection other nominated target research plan will nbsp define scope program nbsp describe party respective responsibility program nbsp describe program anticipated research timeline nbsp include style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman budget intellia activity program budget which must consistent with term this agreement conflict between term research plan term this agreement arises provision this agreement will govern style margin margin bottom text indent font size font family time roman selection exclusive selected target style margin margin bottom margin left text indent font size font family time roman during research term novartis will have right select target novartis selected target exclusive research intellia will have right select target intellia selected target exclusive research each case following manner style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman right forth section nbsp subject following style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom text indent font size font family time roman selection additional target style margin margin bottom margin left text indent font size font family time roman during research term once target have been selected party pursuant section nbsp event later than prior expiration research term novartis will have option select additional target other than intellia selected target exclusive basis each additional selected target subject payment forth section nbsp style margin margin bottom margin left text indent font size font family time roman clarity unless party agree otherwise writing during research term there will more than nbsp target comprising novartis selected target nbsp target comprising additional novartis selected target nbsp target comprising intellia selected target style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman diligence obligation following selection each novartis selected target additional selected target novartis affiliate will commercially reasonable effort research develop commercialize novartis selected product directed such novartis selected target additional selected product directed such additional selected target style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman section nbsp cart program style margin margin bottom text indent font size font family time roman initial research plan cart program cart research plan will agreed upon party later than agreed shall deemed part this agreement cart program party will initially conduct research activity cart field under cart research plan with respect cart program target nominated cart steering committee each nominated cart program target product service relating cart therapeutic target utilizing those nominated cart program target cart research plan will revised from time time reflect development cart research program including remove modify research development activity assigned each party under cart program cart research plan will nbsp define scope cart program nbsp describe party respective responsibility cart program nbsp describe cart program anticipated research timeline nbsp include budget intellia activity cart program cart budget which must consistent with term this agreement conflict between term cart research plan term this agreement arises provision this agreement will govern following creation each cart product novartis affiliate will commercially reasonable effort research develop commercialize cart product directed relevant cart therapeutic target style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp vivo program style margin margin bottom text indent font size font family time roman vivo program generally subject section vivo program party will research potential therapeutic prophylactic palliative product service directed vivo target utilizing intellia platform style margin margin bottom text indent font size font family time roman scope program style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman selection novartis selected vivo target style margin margin bottom margin left text indent font size font family time roman subject section nbsp following vivo selection period novartis select target that proposes included scope vivo program each such target proposed vivo target such event novartis will notify intellia writing such proposal disclose such notice proposed vivo target within after disclosure proposed vivo target intellia will review good faith proposed vivo target determine excluded vivo target excluded vivo target will notify novartis that such proposed vivo target will included vivo program such proposed vivo target novartis selected vivo target excluded vivo target will notify novartis that such proposed vivo target included vivo program novartis selected vivo target purpose this section nbsp excluded vivo target mean event that novartis acting reasonably good faith belief that proposed vivo target wrongfully rejected intellia excluded vivo target novartis will have right submit dispute about such determination accelerated arbitration style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman accordance with procedure section nbsp expert decision find that such proposed vivo target excluded vivo target such proposed vivo target will remain excluded from vivo program hereunder expert decision find that such proposed vivo target wrongfully characterized excluded vivo target will deemed included scope vivo program hereunder from date such decision style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman maximum novartis selected vivo target selected exclusive basis during vivo selection period style margin margin bottom text indent font size font family time roman research plan following selection each novartis selected vivo target novartis sole discretion offer intellia ability participate with novartis research development activity such novartis selected vivo target vivo product directed thereto during research term novartis elect intellia participate such activity intellia accepts sole discretion party will agree upon research plan such novartis selected vivo target each vivo research plan each vivo research plan will revised from time time remove modify research development activity assigned each party thereunder each vivo research plan will nbsp describe party respective research development responsibility with respect relevant novartis selected vivo target vivo product directed thereto nbsp describe anticipated timeline such activity nbsp include budget activity performed intellia vivo budget which must include funding intellia activity that incremental funding under budget cart budget other consistent with term this agreement conflict between term vivo research plan term this agreement arises provision this agreement will govern style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman diligence obligation following selection each novartis selected vivo target novartis affiliate will commercially reasonable effort research develop commercialize novartis selected vivo product directed such novartis selected vivo target style margin margin bottom font size font family time roman section nbsp recording target style margin margin bottom text indent font size font family time roman following selection identification each novartis selected target additional selected target advanced cart target novartis selected vivo target such target will added list maintained deemed exhibit this agreement style margin margin bottom font size font family time roman section nbsp subcontracting research activity style margin margin bottom text indent font size font family time roman each party subcontract research activity performed collaboration third party provided that such third party will have entered into written agreement with such party that includes term condition protecting limiting disclosure confidential information material know other party that least protective such confidential information material know under this agreement requiring such third party personnel assign such party right title interest patent know material created conceived developed connection with performance subcontracted activity extent required such party comply with term condition this agreement such subcontracted activity were performed subcontracting party including article article article style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center governance style margin margin bottom font size font family time roman section nbsp establishment joint steering committee subcommittee style margin margin bottom text indent font size font family time roman joint steering committee party will establish joint steering committee joint steering committee will assume general role leadership collaboration will have responsibility style margin margin bottom margin left text indent font size font family time roman facilitating communication between party with respect research activity contemplated this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman overseeing steering committee cart steering committee vivo steering committee style margin margin bottom margin left text indent font size font family time roman reviewing approving change research plan cart research plan vivo research plan that proposed relevant subcommittee style margin margin bottom margin left text indent font size font family time roman reviewing staffing personnel issue with goal maintaining when determined appropriate continuity personnel collaboration activity reasonably evaluating when determined appropriate change staffing collaboration style margin margin bottom margin left text indent font size font family time roman coordinating strategy relating patent right claiming collaboration product intellectual property style margin margin bottom margin left text indent font size font family time roman prioritizing allocation resource dedicated collaboration style margin margin bottom margin left text indent font size font family time roman informally resolving disagreement between party style margin margin bottom margin left text indent font size font family time roman facilitating discussion between party with respect potential collaboration other activity related crispr system contemplated this agreement style margin margin bottom font size font family time roman will comprised representative from each intellia novartis which unless otherwise agreed upon between party will equal member each party will meet least more agreed upon cambridge massachusetts unless otherwise agreed party style margin margin bottom text indent font size font family time roman research program subcommittee within after initial meeting will appoint member subcommittee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman program steering committee cart program cart steering committee within after finalization first vivo research plan will appoint member subcommittee vivo program vivo steering committee steering committee cart steering committee vivo steering committee each without distinction referred subcommittee collectively referred subcommittee member subcommittee required member provided that each subcommittee will have representative both party subcommittee will provide oversight respective research program will have responsibility style margin margin bottom margin left text indent font size font family time roman determining direction planned activity respective research program compliance with research plan style margin margin bottom margin left text indent font size font family time roman sharing information arising respective research program between party style margin margin bottom margin left text indent font size font family time roman coordinating activity relating filing prosecuting patent application patent claiming collaboration product intellectual property style margin margin bottom margin left text indent font size font family time roman coordinating research activity respective research program compliance with research plan style margin margin bottom margin left text indent font size font family time roman proposing amendment respective research plan which must approved style margin margin bottom font size font family time roman each subcommittee will comprised representative from each intellia novartis which unless otherwise agreed upon between will equal member each party subcommittee member need member each subcommittee will meet least more agreed upon alternation place designated novartis place designated intellia accordance with section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp general rule style margin margin bottom text indent font size font family time roman power committee term each joint steering committee steering committee cart steering committee vivo steering committee each committee will have solely role responsibility assigned this article otherwise expressly forth this agreement committee will have authority amend modify this agreement waive compliance with this agreement make decision that conflict with term condition this agreement create obligation party specified this agreement neither committee either party exercising final decision making pursuant section nbsp will have authority alter increase expand modify amend waive compliance with this agreement committee will terminate expiration research term style margin margin bottom text indent font size font family time roman committee membership either party replace respective committee representative time upon prior written notice other party committee member from either party unable attend participate committee meeting party designated such representative designate substitute representative meeting sole discretion alliance manager appointed intellia novartis pursuant section nbsp will officio member each committee with consent other party each party invite voting employee consultant scientific advisor attend committee meeting discus issue arising collaboration provided that such employee consultant scientific advisor will subject restriction regarding confidentiality confidential information restrictive than provision article viii style margin margin bottom text indent font size font family time roman committee chair each party will appoint member each committee chair such committee meeting each chair chair will nbsp ensure orderly conduct committee meeting nbsp attend each committee meeting either person videoconference telephonically unless style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman otherwise expressly provided herein nbsp prepare issue written minute each meeting within thereafter accurately reflecting discussion decision such meeting chair from either party unable attend participate committee meeting party designated such chair designate substitute chair meeting sole discretion style margin margin bottom text indent font size font family time roman committee meeting meeting will conducted english conducted telephone videoconference person determined chair appropriate provided that than prior written notice been given other party either party also call special meeting committee videoconference teleconference least prior written notice other party such party reasonably belief that significant matter must addressed prior next regularly scheduled meeting later than prior special meeting such party will provide committee with material reasonably adequate enable such committee make informed decision style margin margin bottom text indent font size font family time roman decision making other than forth herein order make decision required hereunder committee must have present person videoconference telephonically least chair each party designee such meeting party will endeavor make decision where required committee consensus chair dispute failure agree arises subcommittee that promptly resolved chair subcommittee cause such dispute failure agree referred joint steering committee resolution dispute failure agree arises which promptly resolved within joint steering committee then matter will referred senior officer party discussion senior officer will attempt good faith resolve such dispute failure agree unanimous consent senior officer resolve such dispute failure agree within matter being referred them then resolution course conduct will determined follows style margin margin bottom margin left text indent font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp decision making authority style margin margin bottom text indent font size font family time roman each party will have decision making authority with respect research activity assigned research plan style margin margin bottom font size font family time roman section nbsp alliance manager style margin margin bottom text indent font size font family time roman each intellia novartis will appoint senior representative posse general understanding research matter alliance manager collaboration each alliance manager each party replace respective alliance manager time upon written notice other accordance with this agreement alliance manager designate substitute temporarily perform function that alliance manager each alliance manager will charged with creating maintaining collaborative work environment within among committee each alliance manager will also responsible nbsp providing single point communication facilitating flow information nbsp ensuring that governance procedure rule forth herein complied with nbsp identifying raising dispute relevant committee discussion timely manner nbsp planning coordinating internal external communication accordance with term this agreement alliance manager will entitled attend committee meeting each alliance manager bring attention committee matter that alliance manager reasonably belief requires attention relevant committee style margin margin bottom font size font family time roman section nbsp cost governance style margin margin bottom text indent font size font family time roman cost incurred each party connection with participation meeting under this article will borne solely such party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp development style margin margin bottom text indent font size font family time roman development generally after research term subject section novartis will solely responsible conducting sole expense development product determines appropriate sole discretion style margin margin bottom text indent font size font family time roman regulatory style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman novartis will have right disclose existence result from clinical trial product conducted under this agreement accordance with standard policy style margin margin bottom font size font family time roman section nbsp manufacturing style margin margin bottom text indent font size font family time roman manufacturing generally style margin margin bottom text indent font size font family time roman manufacturing know assistance style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom font size font family time roman section nbsp commercialization style margin margin bottom text indent font size font family time roman commercialization generally style margin margin bottom margin left text indent font size font family time roman style margin margin bottom text indent font size font family time roman pharmacovigilance extent required applicable within party will agree upon implement procedure mutual exchange adverse event report safety information associated with product detail style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman operating procedure relating adverse event report safety information exchange will subject mutually agreed written pharmacovigilance agreement between party which will entered into within such period style margin margin bottom font size font family time roman section nbsp intellia product style margin margin bottom text indent font size font family time roman intellia will solely responsible nbsp development intellia product nbsp regulatory plan strategy intellia product regulatory filing regulatory approval intellia product filed obtained maintained throughout world name intellia affiliate sublicensees nbsp manufacture supply intellia product nbsp aspect commercialization intellia product intellia will have right disclose existence result from clinical trial intellia product conducted under this agreement accordance with standard policy style margin margin bottom font size font family time roman section nbsp debarment style margin margin bottom text indent font size font family time roman performing obligation under this agreement neither party affiliate will employ person that been debarred under section nbsp federal food drug cosmetic style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center restrictive covenant style margin margin bottom font size font family time roman section nbsp style margin margin bottom text indent font size font family time roman during research term during research term except expressly contemplated this agreement party their affiliate will nbsp engage research development commercialization activity field nbsp grant third party assignment license other right practice intellia intellectual property novartis background intellectual property novartis other background intellectual property collaboration intellectual property field style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman after research term style margin margin bottom margin left text indent font size font family time roman following research term during agreement term intellia affiliate will directly indirectly nbsp themselves behalf collaboration with third party engage research development commercialization activity field with respect nbsp such novartis selected product nbsp novartis selected target that such novartis selected product directed toward style margin margin bottom margin left text indent font size font family time roman nbsp grant third party assignment license other right practice intellia intellectual property collaboration intellectual property field with respect nbsp such novartis selected product nbsp novartis selected target that such novartis selected product directed toward style margin margin bottom margin left text indent font size font family time roman following research term during agreement term novartis affiliate will directly indirectly nbsp themselves behalf collaboration with third party engage research development commercialization activity field with respect nbsp such intellia product nbsp intellia selected target that such intellia product directed toward nbsp grant third party assignment license other right practice novartis background intellectual property novartis other background intellectual property collaboration intellectual property field with respect nbsp such intellia product nbsp intellia selected target that such intellia product directed toward style margin margin bottom margin left text indent font size font family time roman following research term during agreement term intellia affiliate will directly indirectly nbsp themselves behalf collaboration with third party engage research development commercialization activity field with respect such additional selected product nbsp grant third party assignment license other right practice collaboration product intellectual property field with respect such additional selected product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom font size font family time roman section nbsp cart style margin margin bottom text indent font size font family time roman during research term during research term except expressly contemplated this agreement party their affiliate will nbsp engage research development commercialization activity cart field nbsp grant third party assignment license other right practice intellia intellectual property novartis background intellectual property novartis other background intellectual property collaboration intellectual property cart field style margin margin bottom text indent font size font family time roman after research term following research term during agreement term intellia affiliate will directly indirectly nbsp themselves behalf collaboration with third party engage research development commercialization activity cart field nbsp grant third party assignment license other right practice intellia intellectual property collaboration intellectual property cart field with respect nbsp such advanced cart product nbsp cart therapeutic target that such advanced cart product directed toward style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman section nbsp vivo style margin margin bottom text indent font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp permitted third party arrangement style margin margin bottom text indent font size font family time roman nothing this article will prohibit either party from obtaining license assignment other right intellectual property right from third party extent such party deems that such intellectual property right necessary useful exercise right performance obligation under this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center intellectual property style margin margin bottom font size font family time roman section nbsp limited grant research program style margin margin bottom text indent font size font family time roman license grant novartis novartis hereby grant intellia worldwide exclusive license practice novartis background intellectual property novartis other background intellectual property solely extent necessary intellia affiliate perform activity assigned them collaboration style margin margin bottom text indent font size font family time roman license grant intellia intellia hereby grant novartis affiliate worldwide exclusive license practice intellia intellectual property solely extent necessary novartis affiliate perform activity assigned them collaboration style margin margin bottom text indent font size font family time roman sublicensing research program activity subject provision section nbsp each party will have right grant sublicense right forth this section nbsp third party vendor service provider collaborator solely practice connection with good service provided behalf such party collaboration specified research plan cart research plan vivo research plan style margin margin bottom text indent font size font family time roman term research license license contemplated section nbsp section nbsp section nbsp will automatically terminate expiration research term style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp collaboration intellectual property style margin margin bottom text indent font size font family time roman generally notwithstanding inventorship nbsp collaboration product intellectual property will jointly owned party nbsp collaboration platform intellectual property hereby assigned solely owned intellia style margin margin bottom text indent font size font family time roman right collaboration intellectual property except provided article exclusive right forth section nbsp both party their affiliate practice grant license collaboration product intellectual property purpose worldwide without consent accounting other party other than payment contemplated article style margin margin bottom text indent font size font family time roman prosecution maintenance collaboration intellectual property patent right style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman each party will cooperate with other with respect such activity involving collaboration intellectual property including execution such document instrument performance such causing relevant employee execute such document instrument perform such reasonably necessary order permit other party continue preparation filing prosecution maintenance patent right claiming collaboration intellectual property prosecuting party will keep other party reasonably informed material matter relating preparation filing prosecution maintenance post grant proceeding patent right within collaboration product intellectual property patent right within collaboration platform intellectual property including providing such other party with copy material correspondence with applicable patent office will reasonably consider such other party comment relating prosecution maintenance decision defense response post grant proceeding style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman upon either party request where permitted applicable other party will assist requesting party obtain patent term extension supplemental protection certificate their equivalent country extension patent right included collaboration intellectual property each party will promptly notify provide other party with copy allegation alleged lack patentability patent invalidity unenforceability infringement including such allegation pursuant paragraph patent certification third party filing abbreviated drug application application under united state federal food drug cosmetic amended replacement thereof relation application under section nbsp biosimilar other similar patent certification third party foreign equivalent thereof paragraph certification patent right included collaboration intellectual property such notification copy will provided such other party within after novartis intellia applicable receives such certification style margin margin bottom margin left text indent font size font family time roman party disclaiming party elect file application cease prosecution maintenance continue expense prosecution maintenance patent right included collaboration intellectual property which primarily responsible pursuant this section nbsp disclaiming party will provide such notice other party least prior filing payment date other date that requires action connection with such patent right such event disclaiming party will permit other party sole discretion expense file continue prosecution maintenance such patent right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman enforcement defense collaboration intellectual property patent right style margin margin bottom margin left text indent font size font family time roman event either party becomes aware actual suspected infringement claim invalidity lack patentability unenforceability infringement against patent right claiming collaboration intellectual property which collaboration patent right challenge such party shall provide prompt written notice thereof other party provided that party becomes aware collaboration patent right challenge based notification which paragraph certification from third party then party receiving such notification will provide copy such notification other party later than after novartis intellia applicable receives such notification style margin margin bottom margin left text indent font size font family time roman party bringing relevant suit enforcing party shall keep other party reasonably informed development prosecution settlement such suit such other party will provide enforcing party with reasonable assistance connection with suit enforcing party expense including executing reasonably appropriate document cooperating discovery joining party suit required connection with litigation commenced pursuant this section nbsp style margin margin bottom margin left text indent font size font family time roman recovery resulting from such suit will first applied against payment each party cost expense connection therewith style margin margin bottom font size font family time roman section nbsp intellia intellectual property novartis background intellectual property novartis other background intellectual property style margin margin bottom text indent font size font family time roman novartis selected product intellia product style margin margin bottom margin left text indent font size font family time roman novartis selected product intellia hereby grant novartis affiliate worldwide license practice intellia intellectual property collaboration platform intellectual property nbsp during research style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman term research develop product other than intellia product directed intellia selected target under research plan nbsp during after research term research develop commercialize novartis selected product additional selected product field subject section nbsp section nbsp novartis affiliate will have right sublicense right third party vendor service provider collaborator solely practice connection with research development commercialization such novartis selected product additional selected product field style margin margin bottom margin left text indent font size font family time roman intellia product novartis hereby grant intellia affiliate worldwide exclusive license practice novartis background intellectual property nbsp during research term research develop product nbsp during after research term research develop commercialize intellia product field novartis background license subject section nbsp section nbsp intellia affiliate will have right sublicense novartis background license third party vendor service provider collaborator solely practice connection with research development commercialization such intellia product style margin margin bottom text indent font size font family time roman cart product intellia hereby grant novartis affiliate worldwide license practice intellia intellectual property collaboration platform intellectual property nbsp during research term research develop cart product under cart research plan nbsp during after research term research develop commercialize cart product cart field subject section nbsp section nbsp novartis affiliate will have right sublicense such right third party vendor service provider collaborator solely practice connection with research development commercialization such cart product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman vivo product intellia hereby grant novartis affiliate worldwide exclusive license practice intellia intellectual property collaboration platform intellectual property nbsp following effective date remainder research term research develop vivo product under vivo research plan nbsp after research term research develop commercialize novartis selected vivo product vivo field subject section nbsp section nbsp novartis affiliate will have right sublicense such right through multiple tier third party vendor service provider collaborator solely practice connection with research development commercialization such novartis selected vivo product style margin margin bottom text indent font size font family time roman sublicensing right novartis affiliate grant sublicenses license granted section nbsp section nbsp section nbsp intellia affiliate grant sublicenses license granted section nbsp provided that nbsp such sublicense nbsp writing nbsp subject subordinate consistent with term condition this agreement nbsp requires applicable sublicensee comply with applicable term this agreement nbsp with respect novartis affiliate sublicensing party extent required license agreement effect effective date agreement included intellia licensed intellectual property novartis promptly notifies intellia grant each sublicense provides intellia copy final executed sublicense agreement redacted information pertinent this agreement extent that such redaction reasonably impair intellia ability ensure compliance with this agreement license agreement agreement included intellia licensed intellectual property applicable nbsp novartis intellia applicable shall responsible failure sublicensees comply with novartis intellia applicable guarantee compliance each sublicensees with relevant restriction limitation obligation this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman maintenance nbsp compliance license agreement style margin margin bottom margin left text indent font size font family time roman with respect intellectual property right that licensed intellia under license agreement comprising license agreement nbsp intellia will commercially reasonable effort maintain relevant license agreement full force effect nbsp intellia will provide prompt written notice novartis becomes aware receives notice that intellia licensor breach default such license agreement nbsp intellia will commercially reasonable effort cure such breach default nbsp intellia will cause license agreement amended modified that would reasonably expected have material adverse effect novartis right under this agreement nbsp intellia becomes aware that licensors terminated receives notice that licensors intend terminate such license agreement otherwise materially restrict limit intellia novartis right relevant intellectual property right nbsp intellia will provide prompt written notice novartis style margin margin bottom margin left text indent font size font family time roman license granted novartis affiliate under section will subject novartis affiliate their sublicensees compliance effective date with term license agreement term agreement included intellia licensed intellectual property applicable style margin margin bottom text indent font size font family time roman novartis other background intellectual property novartis hereby grant intellia affiliate worldwide exclusive fully paid royalty free license practice novartis other background intellectual property research develop commercialize intellia product therapeutic prophylactic palliative crispr based vivo product behalf intellia affiliate subject section nbsp section nbsp intellia affiliate will have right sublicense license granted under this section nbsp third party vendor service provider collaborator solely practice connection with research style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman development commercialization such intellia product therapeutic prophylactic palliative crispr based vivo product with collaboration behalf intellia affiliate novartis will have right terminate right upon written notice intellia event that intellia affiliate intellia other patent challenge event intellia affiliate intends assert intellia other patent challenge than prior making such assertion intellia shall provide novartis complete written disclosure each basis known intellia such assertion novartis must exercise right terminate intellia right within novartis receipt service process equivalent relevant administrative legal proceeding style margin margin bottom font size font family time roman section nbsp exclusivity style margin margin bottom text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom text indent font size font family time roman cart program style margin margin bottom text indent font size font family time roman vivo program style margin margin bottom font size font family time roman section nbsp license bankruptcy style margin margin bottom text indent font size font family time roman license granted under pursuant this agreement intend license intellectual property contemplated section nbsp united state bankruptcy code equivalent corresponding provision applicable other jurisdiction each licensee retain fully exercise protection right election under applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp implied license style margin margin bottom text indent font size font family time roman license forth this article limited scope those expressly forth this agreement implied license intended created this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center payment style margin margin bottom font size font family time roman section nbsp technology access annual access equity style margin margin bottom text indent font size font family time roman upfront technology access payment novartis will make time payment within after receipt invoice same which will issued after style margin margin bottom text indent font size font family time roman annual access novartis will make annual payment each within receipt invoice same with payment paid novartis intellia later than provided novartis received invoice therefor least prior such date subsequent annual payment invoiced event will payment pursuant this section nbsp exceed aggregate style margin margin bottom text indent font size font family time roman additional selected target each additional selected target novartis will make payment which will paid within receipt invoice same issued upon receipt novartis notice intellia style margin margin bottom text indent font size font family time roman equity investment novartis will have right make investment forth equity agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp research funding payment style margin margin bottom text indent font size font family time roman program cart program style margin margin bottom margin left text indent font size font family time roman novartis will make intellia research funding reimbursement payment research funding payment amount aggregate period unless agreed upon party writing exceed aggregate specifically novartis will make quarterly research funding payment amount within novartis receipt invoice same issued intellia upon applicable such period style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman vivo program pursuant section nbsp party agree that intellia will responsible activity under vivo research plan then such activity performed behalf intellia novartis will reimburse intellia rate consistent with vivo budget included applicable vivo research plan vivo research funding payment novartis will make vivo research funding payment style margin margin bottom text indent font size font family time roman general style margin margin bottom font size font family time roman section nbsp development approval milestone style margin margin bottom text indent font size font family time roman generally forth table below collectively milestone payment will accrue intellia upon achievement novartis affiliate their sublicensees corresponding event milestone with respect each product target that achieves such milestone provided however that style margin margin bottom margin left text indent font size font family time roman product novartis selected target novartis selected target basis additional selected target additional selected target basis applicable milestone payment shall follows style margin margin bottom margin left text indent font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman cart product cart therapeutic target cart therapeutic target basis milestone payment shall follows style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman vivo product novartis selected vivo target novartis selected vivo target basis milestone payment shall follows style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left font size font family time roman example milestone payment example milestone payment provision clause nbsp through above forth exhibit style margin margin bottom font size font family time roman align center table follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center milestone valign bottom nbsp nbsp valign bottom align right style margin margin bottom font size font family time roman align right milestone style margin margin bottom border bottom solid width font size font family time roman align right payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align right style font size font size colspan valign bottom style border solid nbsp bgcolor cceeff style font family time roman font size valign colspan align center valign bottom nbsp nbsp valign bottom table style margin margin bottom text indent font size font family time roman milestone payment novartis will provide intellia with written notice within after novartis determines informed that relevant milestone been achieved novartis will corresponding milestone payment within after receipt invoice same style margin margin bottom text indent font size font family time roman skipped milestone style margin margin bottom font size font family time roman section nbsp royalty product style margin margin bottom text indent font size font family time roman royalty generally novartis affiliate will make royalty payment intellia product product basis following marginal royalty rate royalty style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap valign bottom nbsp nbsp valign bottom align center style border bottom solid marginal royalty nbsp rate bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman royalty duration royalty will payable product product country country basis during royalty term thereafter novartis affiliate their sublicensees right such product such country will royalty free style margin margin bottom text indent font size font family time roman payment royalty within after each calendar quarter during royalty term novartis will provide intellia with report stating sale product sold novartis affiliate during that calendar quarter together with calculation royalty intellia royalty payment will made novartis affiliate bank account indicated intellia within after date receipt novartis invoice indicated amount style margin margin bottom text indent font size font family time roman loss market exclusivity loss market exclusivity product occurs country then remaining period royalty term following such loss market exclusivity sale such country purpose calculation royalty under section nbsp will reduced style margin margin bottom text indent font size font family time roman know only royalty during royalty term relevant product covered valid claim applicable country then long there valid claim such country during royalty term sale such country purpose calculation royalty under section nbsp will reduced style margin margin bottom text indent font size font family time roman minimum royalty notwithstanding multiple reduction that taken pursuant this article event will royalty rate under this agreement fall below applicable royalty rate revised royalty floor forth section nbsp royalty rate forth section nbsp calendar quarter pursuant this section nbsp style margin margin bottom text indent font size font family time roman sample computation sample royalty computation section nbsp forth exhibit style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman payment novartis background license style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left text indent font size font family time roman style margin margin bottom font size font family time roman section nbsp sale milestone product style margin margin bottom text indent font size font family time roman novartis will make each following payment each sale milestone payment when sale milestone style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid sale nbsp milestone payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom text indent font size font family time roman novartis will provide written notice intellia within determination that sale milestone contemplated this section nbsp been achieved will make corresponding sale milestone payment within after date receipt novartis invoice indicated amount style margin margin bottom font size font family time roman section nbsp third party royalty style margin margin bottom text indent font size font family time roman caribou novartis will reimburse intellia provided however that novartis will responsible such reimbursement payment will made within receipt invoice same style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman third party obligation style margin margin bottom margin left text indent font size font family time roman except contemplated section nbsp intellia will remain responsible payment royalty milestone other payment obligation third party under other identified section nbsp intellia intellectual property that been licensed intellia effective date after effective date intellia license intellectual property right third party that cover intellia platform improvement thereto intellia licensed intellectual property then intellia shall make such intellia licensed intellectual property available included license novartis under this agreement notifying novartis intellia licensed intellectual property related agreement including anticipated financial obligation that arise novartis were elect take sublicense such intellectual property right within receiving notice intellia licensed intellectual property novartis elect such intellectual property right intellia intellectual property included intellia licensed intellectual property novartis fails decline make election specified this section within receiving notice from intellia such declined intellectual property right shall included intellia intellectual property excluded intellia licensed intellectual property further excluded intellia licensed intellectual property shall include intellectual property licensed acquired intellia from third party after effective date that intellia licensed intellectual property style margin margin bottom margin left text indent font size font family time roman novartis determines that license other right intellectual property right third party required practice intellia intellectual property other than those already licensed intellia available novartis pursuant term section nbsp above novartis will have right negotiate acquire such right through license will responsible amount paid such third party provided however that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman after effective date novartis license intellectual property right third party that cover intellia platform improvement thereto novartis licensed platform intellectual property then novartis shall make such novartis licensed platform intellectual property available included license granted intellia under section nbsp notifying intellia novartis licensed platform intellectual property related agreement including anticipated financial obligation that arise intellia were elect take sublicense such intellectual property within receiving notice novartis licensed platform intellectual property intellia elect such intellectual property right novartis other background intellectual property included novartis licensed platform intellectual property intellia fails decline make election specified this section within receiving notice from novartis such declined intellectual property right shall included novartis other background intellectual property excluded novartis licensed platform intellectual property style margin margin bottom font size font family time roman section nbsp style margin margin bottom font size font family time roman section nbsp recordkeeping report style margin margin bottom text indent font size font family time roman recordkeeping generally each party will keep complete true accurate book record accordance with accounting standard applicable relation this agreement including case novartis with respect sale royalty case intellia ftes rendered pursuant this agreement intellia sale each party will keep such book record least following calendar year which they pertain each party will promptly notify other advance change accounting standard which record maintained being understood that each party only internationally recognized accounting principle ifrs nbsp gaap style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman audit right each party upon written request cause internationally recognized independent accounting firm auditor which reasonably acceptable other party inspect relevant record other party affiliate verify amount payable party related report statement book account applicable referenced section nbsp before beginning audit auditor will execute undertaking acceptable audited party which auditor agrees keep confidential information reviewed during audit auditor will have right disclose party requesting audit only conclusion regarding payment owed under this agreement style margin margin bottom text indent font size font family time roman inspection book record audited party affiliate will make their record available inspection auditor during regular business hour such place place where such record customarily kept upon receipt reasonable advance notice from party requesting audit record will reviewed solely verify accuracy party financial obligation corresponding this agreement such inspection right will exercised more than once calendar year more than once with respect record covering specific period time addition each party will only entitled audit book record other party from prior calendar year which audit request made party requesting audit will hold strict confidence information received information learned course audit inspection except extent necessary enforce right under this agreement extent required comply with applicable style margin margin bottom text indent font size font family time roman report auditor will provide audit report basis determination both party before considered final final result inspection reveals undisputed underpayment overpayment then underpaid overpaid amount will settled promptly audited party disagrees with finding style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman report will provide other party auditor with reasonably detailed statement ground upon which dispute such finding audit report auditor will undertake complete such further determination within after dispute notice provided which determination will limited disputed matter party will reasonable effort through participation finance representative both company resolve dispute arising relation audit good faith discussion style margin margin bottom text indent font size font family time roman payment audit party requesting audit will such inspection well expense associated with enforcing right with respect payment hereunder provided that nbsp underpayment royalty more than total payment novartis hereunder applicable calendar year discovered error omission novartis expense charged auditor will paid novartis nbsp overpayment novartis more than total payment hereunder applicable calendar year discovered error omission intellia expense charged auditor will paid intellia style margin margin bottom text indent font size font family time roman commercially reasonable effort report starting basis thereafter during agreement term novartis will provide intellia report each novartis selected product additional selected product advanced cart product vivo product that then subject ongoing research development commercialization activity each such report shall detail current status development each such product anticipated date next milestone achieved such product style margin margin bottom font size font family time roman section nbsp payment interest style margin margin bottom text indent font size font family time roman payment will made dollar wire transfer immediately available fund bank account designated writing intellia payment made novartis hereunder designated writing novartis payment made intellia pursuant section nbsp payment which fall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman date that business will next date that business nbsp payment portion thereof hereunder which paid when shall bear simple interest equal lesser nbsp month euribor plus basis point annum nbsp maximum rate permitted applicable calculated number such payment delinquent style margin margin bottom font size font family time roman section nbsp projection style margin margin bottom text indent font size font family time roman intellia novartis acknowledge that nothing this agreement will construed representing estimate projection anticipated sale product that milestone sale level forth above elsewhere this agreement that have otherwise been discussed party merely intended define payment royalty obligation intellia such milestone sale level achieved neither intellia novartis make representation warranty either express implied that will able successfully research develop commercialize product service commercialized that particular sale level such product service will achieved style margin margin bottom font size font family time roman align center article viii style margin margin bottom font size font family time roman align center confidentiality style margin margin bottom font size font family time roman section nbsp undertaking style margin margin bottom text indent font size font family time roman subject other provision this article viii confidential information disclosed party affiliate connection with collaboration under this agreement will maintained confidence otherwise safeguarded recipient party recipient party only such confidential information purpose this agreement pursuant right granted recipient party under this agreement subject other provision this article viii each party will hold confidential such confidential information other party affiliate same manner with same protection such recipient party maintains confidential information event will exercise than reasonable care with style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman respect such confidential information subject other provision this article viii recipient party only disclose confidential information other party employee agent contractor consultant adviser recipient party affiliate licensee sublicensees third party extent reasonably necessary purpose those matter undertaken pursuant this agreement provided that such person bound maintain confidentiality confidential information manner consistent with confidentiality provision this agreement party acknowledge that confidential information been exchanged between party prior effective date pursuant confidentiality agreement party agree that effective date confidentiality agreement hereby terminated without further force effect superseded this article viii obligation between party relating such confidential information exchanged before effective date will governed this article viii style margin margin bottom font size font family time roman section nbsp exception confidentiality style margin margin bottom text indent font size font family time roman obligation under this article viii will apply information extent recipient party demonstrate competent evidence that such information style margin margin bottom margin left text indent font size font family time roman time disclosure becomes after time disclosure known public part public domain through breach this agreement recipient party affiliate style margin margin bottom margin left text indent font size font family time roman known otherwise possession recipient party affiliate prior time disclosure disclosing party affiliate style margin margin bottom margin left text indent font size font family time roman disclosed recipient party affiliate confidential basis third party entitled disclose without breaching confidentiality obligation disclosing party affiliate style margin margin bottom margin left text indent font size font family time roman independently developed behalf recipient party affiliate evidenced written record without reference confidential information disclosed disclosing party affiliate under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman specific aspect detail confidential information will deemed within public domain possession recipient party merely because confidential information embraced more general information public domain possession recipient party further combination confidential information will considered public domain possession recipient party merely because individual element such confidential information public domain possession recipient party unless combination principle public domain possession recipient party style margin margin bottom font size font family time roman section nbsp authorized disclosure style margin margin bottom text indent font size font family time roman addition disclosure allowed under section each party disclose confidential information belonging other party affiliate extent such disclosure necessary following instance nbsp filing prosecuting patent right nbsp connection with seeking obtaining regulatory approval nbsp prosecuting defending litigation permitted this agreement nbsp complying with applicable court order governmental regulation nbsp potential actual investor lender financing partner acquirer merger partner nbsp extent otherwise necessary appropriate connection with exercising license other right granted hereunder recipient party required disclose confidential information disclosing party applicable connection with bona fide legal process such disclosure will breach this agreement provided that recipient party nbsp informs disclosing party soon reasonably practicable required disclosure nbsp limit disclosure required purpose nbsp disclosing party request expense assist attempt object limit required disclosure style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp publicity style margin margin bottom text indent font size font family time roman party will agree mutually acceptable press release issued within following execution this agreement style margin margin bottom text indent font size font family time roman subject section nbsp public announcement concerning existence term this agreement concerning transaction described herein will made either directly indirectly party affiliate without first obtaining written consent other party provided that either party disclose such information required applicable including those incident listing security stock exchange without consent other party provided further that party disclosing such information will nbsp only disclose such information required such applicable nbsp provide reasonable advance notice other party intended disclosure content that disclosure nbsp seek confidential treatment order protective limiting order applicable provision this agreement that reasonably deemed trade secret will permit disclosing party reasonable advance notice opportunity comment such confidential treatment request protective order request style margin margin bottom font size font family time roman section nbsp material transfer style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty covenant style margin margin bottom font size font family time roman section nbsp representation warranty both party style margin margin bottom text indent font size font family time roman each party represents warrant other effective date that nbsp corporation duly organized validly existing good standing under applicable jurisdiction incorporation nbsp full corporate power authority execute deliver perform this agreement taken corporate action required organizational document authorize execution delivery this agreement consummation transaction contemplated style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman this agreement nbsp this agreement constitutes valid binding agreement enforceable against accordance with term except enforceability limited applicable bankruptcy insolvency reorganization receivership moratorium fraudulent transfer other applicable affecting right remedy creditor generally general principle equity nbsp consent approval authorization from governmental authority other third party required obtained such party connection with this agreement have been obtained nbsp execution delivery this agreement other instrument document required executed pursuant this agreement consummation transaction contemplated hereby will nbsp conflict with result breach provision organizational document nbsp result breach agreement which party nbsp violate applicable style margin margin bottom font size font family time roman section nbsp representation warranty intellia style margin margin bottom text indent font size font family time roman intellia represents warrant novartis effective date follows nbsp true correct copy respectively they exist effective date have been provided novartis collectively license agreement nbsp full force effect effective date intellia knowledge fact circumstance that would constitute breach license agreement part party those agreement nbsp intellia granted third party right that would conflict with novartis right granted hereunder there agreement arrangement which intellia affiliate party relating intellectual property right however arising controlled intellia that would limit right granted novartis under this agreement nbsp intellia knowledge patent application included intellia intellectual property effective date have been filed prosecuted accordance with applicable nbsp except forth schedule intellia employee officer consultant have executed agreement have existing obligation under applicable requiring assignment intellia invention made style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman during course result collaboration obligating such individual maintain confidential intellia confidential information well confidential information other party including novartis novartis affiliate that such individual receive conduct collaboration style margin margin bottom font size font family time roman section nbsp representation warranty novartis style margin margin bottom text indent font size font family time roman novartis represents warrant intellia effective date follows nbsp employee officer consultant have executed agreement have existing obligation under applicable requiring assignment novartis invention made during course result collaboration obligating individual maintain confidential novartis confidential information well confidential information other party including intellia that such individual receive conduct collaboration nbsp granted third party right that would conflict with intellia right granted hereunder there agreement arrangement which novartis affiliate party relating intellectual property right however arising controlled novartis that would limit right granted intellia under this agreement nbsp knowledge patent application included novartis intellectual property effective date have been filed prosecuted accordance with applicable nbsp style margin margin bottom font size font family time roman section nbsp covenant style margin margin bottom text indent font size font family time roman compliance with applicable each party will conduct collaboration compliance with applicable including regulation relating health safety environment fair labor practice anti bribery unlawful discrimination style margin margin bottom text indent font size font family time roman personal information privacy course performance collaboration each party acquire personal information defined herein individual from various source country each party will will cause affiliate agent process personal information acquires under style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman connection with this agreement compliance with applicable data protection including data protection european union european economic area switzerland united state various locality therein each party acknowledges that requirement under such data protection exceed requirement applicable confidential information forth article viii each party reasonable prior notice audit other party compliance with such data protection this purpose personal information mean information that used identify describe locate contact individual including nbsp name initial nbsp home other physical address nbsp telephone number nbsp email address online identifier associated with individual nbsp social security number other similar government identifier nbsp employment financial health information nbsp information specific individual physical physiological mental economic racial political ethnic ideological cultural social identity nbsp photograph nbsp date relating individual except year alone nbsp financial account number nbsp genetic material information nbsp business contact information nbsp other information relating individual that alone combination with above used identify individual novartis will anonymize information related novartis material consisting human biological sample style margin margin bottom text indent font size font family time roman conflicting agreement each party covenant that will enter into agreement arrangement undertaking after effective date that would prohibit restrict ability perform obligation forth this agreement materially alter other party right under this agreement style margin margin bottom font size font family time roman section nbsp disclaimer style margin margin bottom text indent font size font family time roman except otherwise expressly provided this agreement party make representation extend warranty kind either express implied with respect intellia intellectual property novartis background intellectual property collaboration intellectual property style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman target product service including warranty validity enforceability patent right title quality merchantability fitness particular purpose performance infringement third party patent other intellectual property right style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnification style margin margin bottom font size font family time roman section nbsp indemnification intellia style margin margin bottom text indent font size font family time roman intellia will indemnify defend hold novartis affiliate their respective employee shareholder officer director successor heir assigns each them novartis indemnitees harmless against loss damage liability expense well reasonable attorney litigation expense collectively loss incurred novartis indemnitee connection with action suit proceeding claim demand third party including personal injury product liability matter third party claim extent that nbsp such loss based arises breach intellia covenant representation warranty forth this agreement excluding such loss that caused negligent reckless intentional omission novartis other novartis indemnitee nbsp such loss relates intellia affiliate their licensee contractor action connection with research development manufacture commercialization intellia selected product style margin margin bottom font size font family time roman section nbsp indemnification novartis style margin margin bottom text indent font size font family time roman novartis will indemnify defend hold intellia affiliate their respective employee shareholder officer director successor heir assigns each them intellia indemnitees harmless against loss incurred intellia indemnitee connection with third party claim extent nbsp such loss based arises breach novartis covenant representation warranty forth this agreement excluding such loss style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman that caused negligent reckless intentional omission intellia other intellia indemnitee nbsp such loss relates novartis affiliate their licensee contractor action connection with research development manufacture commercialization product style margin margin bottom font size font family time roman section nbsp claim procedure style margin margin bottom text indent font size font family time roman each person entitled indemnified other party indemnified party pursuant section nbsp section nbsp will give notice other party indemnifying party promptly after such indemnified party actual knowledge threatened asserted claim which indemnity sought will permit indemnifying party assume sole control defense such claim litigation resulting therefrom provided however style margin margin bottom margin left text indent font size font family time roman that counsel indemnifying party will conduct defense such claim litigation resulting therefrom will approved indemnified party whose approval will unreasonably withheld indemnified party participate such defense indemnified party expense unless indemnified party reasonably concludes that there conflict interest between indemnifying party indemnified party defense such action each which case indemnifying party will reasonable expense firm serving counsel indemnified party which firm will subject approval unreasonably withheld indemnifying party style margin margin bottom margin left text indent font size font family time roman failure indemnified party give notice provided herein will relieve indemnifying party obligation under this agreement extent that failure give notice result harm indemnifying party materially compromise defense such claim style margin margin bottom margin left text indent font size font family time roman indemnifying party defense such claim litigation will consent entry judgment enter into settlement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman except with approval each indemnified party which approval will unreasonably withheld except settlement which imposes only monetary obligation indemnifying party which includes unconditional term thereof giving release from liability respect such claim litigation claimant plaintiff indemnified party style margin margin bottom margin left text indent font size font family time roman each indemnified party will furnish such information reasonable assistance regarding itself claim question indemnifying party reasonably request writing will reasonably required connection with defense such claim litigation resulting therefrom style margin margin bottom font size font family time roman section nbsp mitigation loss style margin margin bottom text indent font size font family time roman each indemnified party will take will procure that other novartis indemnitees where novartis indemnified party other intellia indemnitees where intellia indemnified party take such reasonable step action necessary indemnifying party reasonably require order mitigate loss potential loss under this article nothing this agreement will will deemed relieve party common other duty mitigate loss incurred style margin margin bottom font size font family time roman section nbsp special indirect other loss style margin margin bottom text indent font size font family time roman neither party affiliate will liable contract tort negligence breach statutory duty otherwise special indirect incidental punitive consequential damage economic loss loss profit suffered other party except extent such damage required paid third party part loss which that party provide indemnification under this article such party fraud gross negligence intentional misconduct style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination style margin margin bottom font size font family time roman section nbsp term style margin margin bottom text indent font size font family time roman this agreement commenced will commence effective date unless terminated pursuant section nbsp continue full force effect until fulfillment later nbsp expiration novartis payment obligation hereunder nbsp date expiration last expire patent right that licensed either party forth article agreement term subject survival specified provision this agreement pursuant section nbsp below style margin margin bottom font size font family time roman section nbsp termination cause style margin margin bottom text indent font size font family time roman breach agreement either party material breach this agreement breaching party send written notice breaching party that describes such breach sufficient detail permit breaching party cure such breach capable cure breaching party will have period cure such breach capable cure breach been timely cured notice termination will deemed null void breach been timely cured breach incapable cure breaching party will have right terminate agreement providing written notice agreement applicable research term will terminate upon receipt such notice subject stay termination arbitration pending forth section nbsp style margin margin bottom margin left text indent font size font family time roman novartis terminates this agreement pursuant this section nbsp then style margin margin bottom margin left text indent font size font family time roman following provision will terminate effective date such notice article except provided below article except provided below article except provided below article except provided below article except provided below style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman following provision will survive such termination continue full force effect thereafter section nbsp section nbsp section nbsp section section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp article section nbsp section nbsp excluding section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp those provision forth section nbsp style margin margin bottom margin left text indent font size font family time roman intellia terminates this agreement pursuant this section nbsp then style margin margin bottom margin left text indent font size font family time roman following provision will terminate effective date such notice article article except provided below article except provided below article except provided below article section nbsp section nbsp style margin margin bottom margin left text indent font size font family time roman following provision will survive such termination continue full force effect thereafter section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp article other than section those provision forth section nbsp style margin margin bottom margin left text indent font size font family time roman party agree that termination pursuant this section nbsp remedy invoked only breach adequately remedied through combination specific performance payment money damage that regard money damage payable under this agreement reason breach were materially limited reason section nbsp reason other than exclusion punitive damage will assumed that payment money damage adequate remedy breach unless breaching party elect waive protection section nbsp other than with respect punitive damage resulting amount style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman style margin margin bottom text indent font size font family time roman termination business insolvency either party terminate this agreement immediately written notice other party other party undergoes insolvency event style margin margin bottom margin left text indent font size font family time roman novartis terminates this agreement pursuant this section nbsp then style margin margin bottom margin left text indent font size font family time roman following provision will terminate effective date such notice article except provided below article except provided below article except provided below article except provided below article except provided below style margin margin bottom margin left text indent font size font family time roman following provision will survive such termination continue full force effect thereafter section nbsp section nbsp section nbsp section section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp article section nbsp section nbsp excluding section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp those provision forth section nbsp style margin margin bottom margin left text indent font size font family time roman intellia terminates this agreement pursuant this section nbsp then style margin margin bottom margin left text indent font size font family time roman following provision will terminate effective date such notice article article except provided below article except provided below article except provided below article section nbsp section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman following provision will survive such termination continue full force effect thereafter section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp article other than section those provision forth section nbsp style margin margin bottom text indent font size font family time roman termination challenge intellia will have right terminate this agreement entirety upon written notice nbsp novartis event that novartis affiliate directly indirectly challenge legal administrative proceeding patentability enforceability validity patent right within intellia intellectual property collaboration platform intellectual property except defense against claim action proceeding asserted intellia against novartis affiliate sublicensees novartis patent challenge provided that intellia will have right terminate this agreement under this section nbsp such novartis patent challenge sublicensee such novartis patent challenge dismissed within intellia notice novartis under this section nbsp thereafter continued effect such termination intellia provision that survive terminated such termination will same that forth section nbsp above style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman termination material failure termination without cause style margin margin bottom margin left text indent font size font family time roman material failure style margin margin bottom margin left text indent font size font family time roman subject section nbsp novartis will have right terminate this agreement entirety following event occurs style margin margin bottom margin left text indent font size font family time roman patent application claiming priority patent application neither regent university california berkeley berkeley emmanuelle charpentier charpentier file claim with united state patent nbsp trademark office uspto june nbsp sufficient under allow uspto initiate interference with more claim patent nbsp patent interference trigger style margin margin bottom margin left text indent font size font family time roman neither uspto allows european patent office patent authority office france germany italy spain united kingdom grant patent claim from patent application claiming priority patent application their european counterpart december nbsp grant trigger style margin margin bottom margin left text indent font size font family time roman owner licensee patent brings suit against novartis before december nbsp claiming that activity specifically encompassed research plan infringe independent claim patent litigation trigger provided however that novartis will have right exercise litigation trigger nbsp owner licensee patent brings infringement suit against novartis under patent solely activity novartis performing independently with other third party outside collaboration developing crispr related research tool nbsp owner licensee patent bring infringement suit against novartis under style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman patent counterclaim response judicial patent agency proceeding suit initiated intellia novartis against them style margin margin bottom margin left text indent font size font family time roman event described section nbsp occurred novartis desire terminate this agreement novartis will comply with following before such termination will deemed effective style margin margin bottom margin left text indent font size font family time roman novartis will send written notice intellia intent terminate this agreement identifying relevant trigger within following applicable date event specified section nbsp style margin margin bottom margin left text indent font size font family time roman following intellia receipt such termination notice novartis intellia will have period discus good faith whether continue with collaboration pursuant term this agreement party agree continue collaboration novartis termination notice will deemed withdrawn this agreement will continue full effect such term party decide continue collaboration novartis termination notice will deemed effective from date notice style margin margin bottom margin left text indent font size font family time roman following intellia receipt such termination notice intellia will have period seek resolve which period extended mutual agreement party intellia successful novartis termination notice will deemed withdrawn this agreement will continue full force effect intellia successful novartis termination notice will deemed effective from date notice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman novartis terminates this agreement permitted pursuant this section nbsp nbsp provision will terminate except following which will survive such termination continue full force effect thereafter section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp those provision forth section nbsp nbsp novartis will intellia accrued financial obligation date such termination will continue financial obligation under article period following novartis notice pursuant section nbsp style margin margin bottom margin left text indent font size font family time roman without cause novartis will have right terminate this agreement without cause effective upon written notice intellia novartis terminates this agreement pursuant this section nbsp nbsp provision other than provision forth section nbsp will terminate except following which will survive such termination continue full force effect thereafter section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp section nbsp those provision forth section nbsp nbsp novartis will intellia accrued future financial obligation research term continued until natural expiration five year from effective date including research funding payment intellia fully performed without need intellia true expense under section nbsp style margin margin bottom font size font family time roman section nbsp survival style margin margin bottom text indent font size font family time roman termination will without prejudice party right seek damage connection with such event except where explicitly provided elsewhere herein termination this agreement reason will affect nbsp obligation which have style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman accrued date termination expiration including novartis payment obligation nbsp obligation right which expressly from context thereof intended survive termination expiration this agreement including article article viii article article this article article style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center miscellaneous style margin margin bottom font size font family time roman section nbsp governing jurisdiction style margin margin bottom text indent font size font family time roman this agreement claim between party arising relating this agreement transaction that contemplates including intellectual property right described herein their validity interpretation construction performance enforcement will exclusively governed substantive commonwealth massachusetts without regard conflict principle style margin margin bottom font size font family time roman section nbsp dispute style margin margin bottom text indent font size font family time roman referral executive either party refer question difference dispute that arise concerning construction meaning effect this agreement concerning right liability party hereunder senior officer intellia novartis will attempt good faith resolve such question difference dispute question difference dispute resolved within such referral either party will free initiate arbitration proceeding outlined section nbsp below avoidance doubt difference dispute arising from shall resolved accordance with section nbsp style margin margin bottom margin left font size font family time roman arbitration style margin margin bottom margin left text indent font size font family time roman general arbitration unless section nbsp applicable question difference dispute relating this agreement that resolved through informal mean forth section nbsp will exclusively finally resolved arbitration administered accordance with rule judicial administration arbitration service effect time style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman submission arbitration proceeding will conducted boston massachusetts before mutually acceptable arbitrator selected jointly party from panel person experienced pharmaceutical life science industry accordance with rule party unable reach agreement each party will have right discovery provided federal rule civil procedure arbitral proceeding pursuant this section nbsp either party apply arbitrator interim injunctive relief seek from court having jurisdiction injunctive provisional relief necessary protect right property that party pending resolution matter pursuant this section nbsp party will have right represented counsel judgment award rendered arbitrator will final binding party will governed term condition hereof including limitation damage forth section nbsp party agree that such judgment award enforced court competent jurisdiction party agree that applicable statute limitation time based defense such estoppel laches will tolled while dispute resolution procedure forth this section nbsp pending prevailing party will bear prevailing party cost expense attorney arbitration except that arbitrator order instead each party bear cost expense attorney arbitration arbitrator find that prevailing party position issue dispute relative merit party that prevail arbitration proceeding instance will arbitrator expense administrative arbitration proceeding decision arbitrator will deemed confidential information each party will subject article viii style margin margin bottom margin left text indent font size font family time roman accelerated arbitration extent arbitration matter involves question difference dispute that either party submit accelerated arbitration resolution permitted under other provision style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman this agreement dispute regarding proper characterization question difference dispute subject resolution under this section nbsp opposed section nbsp following procedure will also apply style margin margin bottom margin left text indent font size font family time roman style margin margin bottom text indent font size font family time roman stay termination purported termination this agreement under section nbsp will automatically stayed during pendency arbitration proceeding commenced under section nbsp style margin margin bottom font size font family time roman section nbsp waiver style margin margin bottom text indent font size font family time roman provision this agreement waived except writing both party hereto failure delay either party hereto exercising right remedy hereunder under applicable will operate waiver thereof waiver right remedy subsequent occasion style margin margin bottom font size font family time roman section nbsp severability style margin margin bottom text indent font size font family time roman should more provision this agreement become invalid then party hereto will attempt agree upon valid provision substitution invalid provision which their economic effect come close invalid provision that reasonably assumed that party would have accepted this agreement with those provision party unable agree such valid provision invalidity such more provision this agreement will affect validity agreement whole unless invalid provision such essential importance this agreement that reasonably presumed that party would have entered into this agreement without invalid provision style margin margin bottom font size font family time roman section nbsp government style margin margin bottom text indent font size font family time roman applicable should make impossible prohibit restrain modify limit material obligation party under this agreement party affected will have right option suspend terminate this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman such country good faith negotiation between party make such modification therein necessary fairly address impact thereof successful after reasonable period time exceed producing mutually acceptable modification this agreement style margin margin bottom font size font family time roman section nbsp export control style margin margin bottom text indent font size font family time roman this agreement made subject restriction concerning export material technology from united state that imposed upon related either party this agreement from time time government united state furthermore each party will export directly indirectly technical information acquired from other party under this agreement product service using such technical information country which united state government agency thereof time export requires export license other governmental approval without first obtaining written consent from department commerce other agency united state government when required applicable statute regulation style margin margin bottom font size font family time roman section nbsp assignment style margin margin bottom text indent font size font family time roman neither party assign this agreement right under this agreement except otherwise expressly provided this agreement delegate performance under this agreement except affiliate third party successor substantially asset business such party which this agreement relates whether merger sale stock sale asset reorganization other transaction purported assignment delegation party contravention this section nbsp will option other party null void effect assignment will release either party from responsibility performance accrued obligation such party hereunder this agreement will binding upon enforceable against administrator legal representative successor party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp affiliate style margin margin bottom text indent font size font family time roman each party perform obligation hereunder personally through more affiliate each party will solely responsible omission affiliate neither party will permit affiliate commit including omission that such party prohibited hereunder from committing directly material breach term condition this agreement party affiliate will construed material breach such party under this agreement style margin margin bottom font size font family time roman section nbsp counterpart style margin margin bottom text indent font size font family time roman this agreement executed counterpart each which will deemed original both which will constitute same agreement style margin margin bottom font size font family time roman section nbsp agency style margin margin bottom text indent font size font family time roman nothing herein contained will deemed create agency joint venture amalgamation partnership similar relationship between novartis intellia their respective affiliate notwithstanding provision this agreement neither party this agreement will time enter into incur hold itself third party having authority enter into incur behalf other party commitment expense liability whatsoever contract expense liability connection with relating obligation each party under this agreement will made paid undertaken exclusively such party behalf agent representative other style margin margin bottom font size font family time roman section nbsp notice style margin margin bottom text indent font size font family time roman notice request demand other communication between party with respect provision this agreement will sent address below such other address designated party other notice pursuant hereto internationally recognized courier fedex with receipt signature required address below style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman novartis style margin margin bottom margin left font size font family time roman novartis institute biomedical research style margin margin bottom margin left font size font family time roman massachusetts avenue style margin margin bottom margin left font size font family time roman cambridge style margin margin bottom margin left font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp attention global head strategic alliance style margin margin bottom text indent font size font family time roman with required copy style margin margin bottom margin left font size font family time roman novartis institute biomedical research style margin margin bottom margin left font size font family time roman massachusetts avenue style margin margin bottom margin left font size font family time roman cambridge style margin margin bottom margin left font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp attention general counsel style margin margin bottom text indent font size font family time roman intellia style margin margin bottom margin left font size font family time roman intellia therapeutic style margin margin bottom margin left font size font family time roman brookline street suite style margin margin bottom margin left font size font family time roman cambridge style margin margin bottom margin left font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp attention chief executive officer style margin margin bottom text indent font size font family time roman with required copy style margin margin bottom margin left font size font family time roman intellia therapeutic style margin margin bottom margin left font size font family time roman brookline street suite style margin margin bottom margin left font size font family time roman cambridge style margin margin bottom margin left font size font family time roman attention general counsel style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman goodwin procter style margin margin bottom margin left font size font family time roman exchange place style margin margin bottom margin left font size font family time roman state street style margin margin bottom margin left font size font family time roman boston massachusetts style margin margin bottom margin left font size font family time roman attention arthur mcgivern nbsp karen spindler style margin margin bottom font size font family time roman section nbsp style margin margin bottom margin left text indent font size font family time roman style margin margin bottom text indent font size font family time roman section nbsp securitization style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman section nbsp third party beneficiary style margin margin bottom text indent font size font family time roman term condition this agreement express implied exist only benefit party their respective successor permitted assigns except under article this agreement confer enforceable right remedy upon person other than party style margin margin bottom font size font family time roman section nbsp entire agreement amendment style margin margin bottom text indent font size font family time roman this agreement together with exhibit contains entire understanding party relating matter referred herein only amended written document duly executed behalf respective party expressly referencing this agreement avoidance doubt equity agreement remain full force effect with respect their term provided that disclosure after effective date shall governed term this agreement style margin margin bottom font size font family time roman section nbsp force majeure style margin margin bottom text indent font size font family time roman neither novartis intellia will liable failure delay performing obligation forth this agreement neither will deemed breach such obligation such failure delay natural disaster cause reasonably beyond control novartis intellia provided that party affected will promptly notify other force majeure condition will exert reasonable effort eliminate cure overcome such cause resume performance obligation soon possible style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right license collaborative research agreement style margin margin bottom font size font family time roman executed effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan style margin margin bottom font size font family time roman novartis institute style margin margin bottom font size font family time roman biomedical research valign bottom nbsp valign bottom valign bottom nbsp valign colspan intellia therapeutic style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman scott brown valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman nessan bermingham style font family time roman font size valign name valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman scott brown valign bottom nbsp valign bottom valign bottom nbsp valign bottom name valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman nessan bermingham style font family time roman font size valign title valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman general counsel valign bottom nbsp valign bottom valign bottom nbsp valign bottom title valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman chief executive officer table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center sample invoice style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center invoice valign bottom nbsp nbsp valign bottom style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp nbsp valign align center style margin margin bottom font size font family time roman align center valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign bottom style font size height height colspan height colspan height colspan height colspan height colspan height colspan height colspan style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign align center valign bottom nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign bottom style font size height height colspan height colspan height colspan height colspan height colspan height colspan height colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign valign bottom nbsp nbsp valign align right valign bottom nbsp nbsp valign align center valign bottom nbsp nbsp valign bottom table style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center novartis background intellectual property style margin margin bottom font size font family time roman compound known novartis style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center novartis other background intellectual property style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman novartis patent family valign bottom nbsp nbsp valign bottom style border bottom solid width font size font family time roman title style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center sample calculation research cost style margin margin bottom font size font family time roman intellia novartis research year style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman name valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center collaboration program valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center collaboration program valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center collaboration program valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center collaboration program valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center total valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center nbsp expense nbsp style font family time roman font size valign nbsp smith valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign nbsp smith valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign nbsp smith valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign nbsp smith valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign nbsp total valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule promulgated under security amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman example royalty calculation royalty product under section nbsp style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman example royalty calculation royalty product under section nbsp style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center body html text document